“
“We report the case of a 38-year-old male patient with a 1-year https://www.selleckchem.com/products/Lapatinib-Ditosylate.html history of progressively blurred vision in his left eye. He visited our clinic and underwent a series of ophthalmologic examinations including computed tomography, fluorescein angiography and optical coherence tomography. The final diagnosis was optic nerve head drusen and combined hamartoma of the retina and retinal pigment epithelium in his left eye.”
“OBJECTIVE
To determine the frequency and classification of adverse events (AEs) associated with fractionated
carbon dioxide (CO(2)) laser treatment.
METHODS
A retrospective evaluation of 373 successive fractionated 10,600-nm CO(2) laser treatments in 287 patients conducted in a single center. AEs of laser therapy, including onset, duration, and treatment, were identified and analyzed through chart review, telephone calls, and email.
RESULTS
Three hundred seventy-three treatments resulted in 47 AEs (12.6%) in 40 patients (13.9%). The most frequent AEs were allergic or contact dermatitis (4.6%) acneiform breakout (3.5%), prolonged erythema (1.1%), and herpes simplex virus outbreaks (1.1%).
AEs were distributed across different ages, skin types (95% Type II, III, 5% Type IV), and laser parameters. Three of 22 patients (13.6%) with two body areas treated simultaneously and six of 16 patients (37.5%) with three body areas treated SBE-β-CD Microbiology inhibitor simultaneously experienced AEs. Because of the multiple areas treated, some patients experienced multiple
AEs. Six AEs were documented in the three patients who underwent two concurrent treatments, and a total of nine AEs were documented in six patients who underwent three concurrent treatments. The 24 patients who had subsequent additional treatments had three documented AEs (12.5%).
CONCLUSION
CO(2) fractionated laser skin treatment is associated with a this website relatively low complication rate when one body location is treated, but the complication rate increases with three concurrent treatments of multiple body locations. Subsequent treatments of the same body location after a healing period of 1 to 6 months resulted in no greater risk of AEs.
Mitchel P. Goldman, MD, is a consultant to and stockholder in Lumenis.”
“Background: The purpose of this study was to assess the prevalence of bipolar spectrum disorder (BSD) in the general Korean population.
Methods: A sample of college students (n = 1026) was stratified to reflect geographical differences accurately in Korean college students. The Korean version of the Mood Disorder Questionnaire (K-MDQ) was administered and an epidemiological survey carried out between November 2006 and February 2007. BSD was defined as a score of at least seven K-MDQ symptoms that co-occurred and resulted in minimal or more functional impairment.
Results: The prevalence of BSD was 18.6% (95% confidence interval [CI] 16.2-21.0) in total, being 19.8% (95% CI 16.3-23.2) in men and 17.5% (95% CI 14.2-20.8) in women.